Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...